Literature DB >> 2148540

Effects of mitogens and lymphokines on the regulation of the immune response to HBs antigen in vitro.

I Knöller1, U J Hoffmann, H H Werchau, W König.   

Abstract

We studied the immunoregulatory mechanisms of responsiveness and non-responsiveness to hepatitis B (HB) vaccine by analysing the influence of HB surface antigen (HBsAg) on lymphokine- or mitogen-stimulated peripheral lymphocytes from healthy volunteers. Stimulation with pokeweed mitogen (PWM) led to a reduced production of polyclonal IgG from responder cells compared to non-responder lymphocytes. PWM did not enhance the HBs-specific IgG production from responder lymphocytes when the cells were obtained at Day 10 after the last vaccination. A slight reduction of the proliferative response was observed when lymphocytes of non-responders were stimulated with phytohaemagglutinin (PHA) or concanavalin A (Con A). Production of HBs-specific antibodies was enhanced by incubating responder lymphocytes with interleukin-4 (IL-4). The HBs antigen itself did not modulate the expression of the CD23 B-cell differentiation antigen in unseparated lymphocytes. However, CD23 expression induced by low doses of IL-4 was markedly enhanced in an antigen-specific way. Our data indicate that HBs antigen enhances the lymphokine-induced CD23 expression, whereas the mitogen-induced CD23 expression is not affected. Lymphocytes obtained from non-responders exerted a reduced expression of CD25 surface antigen compared to responder lymphocytes. Exogeneous addition of IL-2 in the absence or presence of HBsAg induced a marked enhancement of the IL-2 receptor expression in responder lymphocytes. Furthermore, no significant modulation of CD25 expression was observed in non-responder lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2148540      PMCID: PMC1384431     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Alterations in the immune response of nonresponders to the hepatitis B vaccine.

Authors:  M J Nowicki; M J Tong; R E Bohman
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

2.  An improved rosetting assay for detection of human T lymphocytes.

Authors:  M E Kaplan; C Clark
Journal:  J Immunol Methods       Date:  1974-07       Impact factor: 2.303

3.  In vitro production of IgE-binding factors by human mononuclear cells.

Authors:  G Delespesse; M Sarfati; M Rubio-Trujillo
Journal:  Immunology       Date:  1987-01       Impact factor: 7.397

4.  In vitro anti-HBs antibody synthesis from anti-hepatitis B vaccine recipients.

Authors:  V Barnaba; M Levrero; G Ruberti; A van Dyke; A Perrone; A Musca; F Balsano
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

5.  Activation of human peripheral blood B cells following immunization with hepatitis B surface antigen vaccine.

Authors:  T R Cupps; P K Goldsmith; D J Volkman; J L Gerin; R H Purcell; A S Fauci
Journal:  Cell Immunol       Date:  1984-06       Impact factor: 4.868

6.  Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses.

Authors:  S C Meuer; M Hauer; P Kurz; K H Meyer zum Büschenfelde; H Köhler
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

7.  Immunologic effects of interferon-alpha in man: treatment with human recombinant interferon-alpha suppresses in vitro immunoglobulin production in patients with chronic type B hepatitis.

Authors:  M Peters; D M Walling; K Kelly; G L Davis; J G Waggoner; J H Hoofnagle
Journal:  J Immunol       Date:  1986-11-15       Impact factor: 5.422

8.  Expression of Fc epsilon receptors on activated human T lymphocytes.

Authors:  J C Prinz; N Endres; G Rank; J Ring; E P Rieber
Journal:  Eur J Immunol       Date:  1987-06       Impact factor: 5.532

9.  In vitro synthesis of antibody to hepatitis B virus antigen by circulating lymphocytes from chronic HBsAg carriers and patients with acute hepatitis B.

Authors:  K Murase; S Kakumu; A Tsubouchi; K Yoshioka; N Sakamoto
Journal:  Gastroenterol Jpn       Date:  1986-04

10.  Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes.

Authors:  T Defrance; J P Aubry; F Rousset; B Vanbervliet; J Y Bonnefoy; N Arai; Y Takebe; T Yokota; F Lee; K Arai
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.